highly significantp ≤ 0.003
Highly significant metabolic and morphologic response was seen in the prednisolone ( p ≤ 0.003) and the combination therapy group ( p ≤ 0.001).
Highly significant metabolic and morphologic response was seen in the prednisolone ( p ≤ 0.003) and the combination therapy group ( p ≤ 0.001).
In the rituximab monotherapy group, significant decreases were observed only after two doses of SUV max , SUV mean , MAV, CT rim and CT cc ( p = 0.028–0.046) with a strong trend towards improvement also in SUV peak ( p = 0.063), while after application of only one dose there was no significant response ( p = 0.109-1.000).